Company intelligence
Myogenes
Helping GPs and Psychiatrists choose the right medication for their patients. Psychiatric Testing | DNA Testing
Medical Practices
Elstree, GB
13 employees
Founded 2016
5 public signals
About Myogenes
Helping GP's and Psychiatrists choose the right medication for their patients. Psychiatric Testing | DNA Testing | Cancer Testing | Pharmacogentic Testing
Verified activity
Signals from Myogenes
5 published signals
Strategy & Corporate Development
Myogenes included the ACKR1/Duffy-null genotype test in the NHS National Genomic Test Directory.
Reported by Marc Howells
Strategy & Corporate Development
Myogenes commissioned a service evaluation across mental health trusts to assess clozapine access, initiation, discontinuation, and time to initiation, disaggregated by ethnicity.
Reported by Marc Howells
Strategy & Corporate Development
Myogenes adopted the CERSI-PGx guideline into the national clozapine pathway.
Reported by Marc Howells
Research & Knowledge
Myogenes published evidence showing that ACKR1/Duffy-null genotype testing in national suicide prevention and mental health strategy can be recognized as an enabler of timely clozapine access.
Reported by Marc Howells
Research & Knowledge
Myogenes published findings from the Maudsley clozapine clinic showing that a single buccal-swab genotype test results in ~14 days, >99% analytical sensitivity and specificity, with findings published in the British Journal of Psychiatry.
Reported by Marc Howells